Amy C. Moore: Why Lung Cancer Advocacy Matters to Me
Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, shared a post on LinkedIn:
“I have officially been in my new role for 5 months now. I feel like I have settled in and hope I am making valuable contributions.
This morning, a memory popped up reminding me of why I made this pivot.
I had been helping a family for several years following the young mother’s diagnosis with NSCLC. Her cancer was discovered incidentally following a pregnancy loss. Sadly, her tumor outsmarted the targeted therapy she was on, and it transformed to SCLC. She passed away last summer, two days before her child’s birthday.
Advocacy work can be soul-crushing. The losses mount, people’s lives are cut short. Families are forever changed.
I am here to remind you that anyone with lungs – that’s me, that’s you – can get lung cancer. And I will continue to do what I can to bring awareness and to try to bring new solutions to the table.”
More posts featuring Amy C. Moore.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023